Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

9.53
Delayed Data
As of Sep 01
 -0.56 / -5.55%
Today’s Change
6.38
Today|||52-Week Range
13.84
-15.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. It applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack Pharmaceuticals was founded by Anthony J. Sinskey, Gavin MacBeath and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Contact Information

Merrimack Pharmaceuticals, Inc.
One Kendall Square
Cambridge Massachusetts 02139
P:(617) 441-1000
Investor Relations:
(617) 441-7602

Employees

Shareholders

Individual stakeholders8.69%
Mutual fund holders42.68%
Other institutional27.67%

Top Executives

Robert J. MulroyPresident, Chief Executive Officer & Director
William M. McClementsHead-Corporate Operations
Yasir B. Al-WakeelChief Financial Officer
Jeffrey A. MunsieVice President & General Counsel
Eliel BayeverVice President & Medical Director-MM-398